About Solon Ventures Limited
Solon is a venture capital firm based in the UK that invests in the healthcare and technology sectors.
We provide support and capital to entrepreneurs to develop businesses across all stages of development.
Solon's approach is based on dedication, partnership and integrity.
On 10th January 2017, Pharmaron announced the acquisition of Xceleron Inc, the trading subsidiary of Solon Ventures portfolio company AMS Sciences Limited.
On 15th June 2015, Circassia Pharmaceuticals (LSE: CIRL) announced the acquisition of Solon Ventures portfolio company Prosonix Limited.
On 7th July 2014, Concept Life Sciences announced the acquisition of Solon Ventures portfolio company Peakdale Molecular Limited.